ThirtyFiveBio Competitors and Similar CompaniesClear all
ThirtyFiveBio's competitors and similar companies include Shanghai OPM Biosciences and Medpace.
 ThirtyFiveBio ThirtyFiveBio specializes in biotechnology research, offering therapies for patients affected by GPR35. |  Shanghai OPM Biosciences Shanghai OPM Biosciences (上海奥浦迈生物科技股份有限公司) is a biotechnology company that produces biopharmaceuticals. | ||
Founding Date | Founding Date 2021 | Founding Date 2013 | Founding Date 1992 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations HQ | Locations Shanghai, CN HQ Pleasanton, US | Locations Cincinnati, US HQ Buenos Aires, AR South Yarra, AU Leuven, BE Leuven, BE Sao Paulo, BR Toronto, CA see more |
Employees | Employees 15 | Employees 32815% increase | Employees 5,90013% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥294.6m (FY, 2024) | Revenue (est.) $2.5b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥139.6m (FY, 2024) | Cost of goods $1.8b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥155.4m (FY, 2024) | Gross profit $760.6m (FY, 2025) |
Net income | Net income N/A | Net income ¥20.2m (FY, 2024) | Net income $451.1m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Shanghai OPM Biosciences
HQ
Shanghai, CN
Employees
328↑ 15% increase
Shanghai OPM Biosciences (上海奥浦迈生物科技股份有限公司) is a biotechnology company that produces biopharmaceuticals.
View company
Medpace
HQ
Cincinnati, US
Employees
5,900↑ 13% increase
Medpace is a clinical contract research organization (CRO).
View company